Search results
Biomarin Pharma earnings beat by $0.39, revenue fell short of estimates
Investing.com· 5 days agoBiomarin Pharma earnings beat by $0.39, revenue fell short of estimates
One Athira Pharma Insider Raised Their Stake In The Previous Year
Simply Wall St. via Yahoo Finance· 6 days agoViewing insider transactions for Athira Pharma, Inc.'s (NASDAQ:ATHA ) over the last year, we see...
We've Got You 'Covered' on This Bet on Big Pharma
TheStreet.com· 11 hours agoThe return on this solid value play can be enhanced by a simple covered call strategy. Today we are teeing up Big Pharma name for a covered call trade...
India Pharma Sector Set for Robust Growth Amidst Margin Concerns By Investing.com
Investing.com· 7 days agoNotably, the sector continues to trade at valuations exceeding one standard deviation above its...
InnoCare Pharma Limited expects multiple drug products to reach approval
China Daily· 1 day agoInnoCare Pharma Limited, a Hong Kong-listed Chinese biopharma company, said that at least five of the company's innovative drug products are expected to get approved and enter ...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 3 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Will BridgeBio Pharma (BBIO) Report Negative Q1 Earnings? What You Should Know
Zacks via Yahoo Finance· 4 days agoBridgeBio Pharma (BBIO) doesn't possess the right combination of the two key ingredients for a...
ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...
WDTN-TV 2 Dayton· 4 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
“We fell here by chance, but the bet on Terrasa cannot be changed.”
Hardwood Paroxysm· 2 days agoOn Sunday, April 28, Kern Pharma was born 25 years ago, after the Indukern Group bought the Roche...
Morgan Stanley Reiterates Equal Weight Rating for Ascendis Pharma A/S (NASDAQ:ASND)
ETF DAILY NEWS· 5 days agoAscendis Pharma A/S (NASDAQ:ASND – Get Free Report)‘s stock had its “equal weight” rating reiterated by equities researchers at Morgan Stanley in a research note issued on ...